litlas
ログインアカウント作成

Stephen B. Hanauer

1986–2025 年に発表

別表記
STEPHEN B. HANAUER · Stephen B Hanauer
198
論文数
80,425
被引用数
123
h 指数
189
i10 指数

被引用数

Stephen B. Hanauer の年別被引用数1987 年: 被引用 1 件1988 年: 被引用 3 件1989 年: 被引用 8 件1990 年: 被引用 8 件1991 年: 被引用 22 件1992 年: 被引用 9 件1993 年: 被引用 17 件1994 年: 被引用 17 件1995 年: 被引用 29 件1996 年: 被引用 26 件1997 年: 被引用 36 件1998 年: 被引用 54 件1999 年: 被引用 138 件2000 年: 被引用 214 件2001 年: 被引用 273 件2002 年: 被引用 503 件2003 年: 被引用 524 件2004 年: 被引用 530 件2005 年: 被引用 594 件2006 年: 被引用 664 件2007 年: 被引用 737 件2008 年: 被引用 710 件2009 年: 被引用 634 件2010 年: 被引用 714 件2011 年: 被引用 712 件2012 年: 被引用 583 件2013 年: 被引用 715 件2014 年: 被引用 764 件2015 年: 被引用 763 件2016 年: 被引用 719 件2017 年: 被引用 787 件2018 年: 被引用 759 件2019 年: 被引用 2,379 件2020 年: 被引用 2,347 件2021 年: 被引用 1,888 件2022 年: 被引用 1,541 件2023 年: 被引用 1,250 件2024 年: 被引用 1,865 件2025 年: 被引用 823 件2026 年: 被引用 25 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 4,732 件、この内訳の 23.5%イギリス: 引用元論文 1,608 件、この内訳の 8%カナダ: 引用元論文 1,353 件、この内訳の 6.7%イタリア: 引用元論文 1,168 件、この内訳の 5.8%中国: 引用元論文 1,112 件、この内訳の 5.5%ドイツ: 引用元論文 1,110 件、この内訳の 5.5%フランス: 引用元論文 1,072 件、この内訳の 5.4%オランダ: 引用元論文 754 件、この内訳の 3.8%ベルギー: 引用元論文 703 件、この内訳の 3.5%日本: 引用元論文 606 件、この内訳の 3%スペイン: 引用元論文 589 件、この内訳の 2.9%オーストラリア: 引用元論文 520 件、この内訳の 2.6%
0%23.5%その他 23.8%

機関

分野

  • Biochemistry, Genetics and Molecular Biology58.6%
  • Medicine26.1%
  • Immunology and Microbiology9.7%
  • Neuroscience1.3%
  • Nursing1.1%
  • Agricultural and Biological Sciences1%
  • その他2.2%

トピック

  • Inflammatory Bowel Disease20.2%
  • Microscopic Colitis7%
  • Gut microbiota and health3.5%
  • Rheumatoid Arthritis Research and Therapies3.5%
  • Autoimmune and Inflammatory Disorders3.1%
  • Biosimilars and Bioanalytical Methods2.1%
  • その他60.6%

共著者

全論文

検索で開く
  1. Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis

    著者: Brian G. Feagan, Paul Rutgeerts, Bruce E. Sands, Stephen B. Hanauer, Jean‐Frédéric Colombel, William J. Sandborn, Gert Van Assche, Jeffrey Axler, Hyo Jong Kim, Silvio Danese, Irving H. Fox, Catherine Milch, Serap Sankoh, Tim Wyant, Jing Xu, Asit Parikh - New England Journal of Medicine 2013 被引用: 2,852

  2. Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease

    著者: Brian G. Feagan, William J. Sandborn, Christopher Gasink, Douglas Jacobstein, Yinghua Lang, Joshua R. Friedman, Marion Blank, Jewel Johanns, Long-Long Gao, Miao Ye, Omoniyi J. Adedokun, Bruce E. Sands, Stephen B. Hanauer, Séverine Vermeire, Stephan R. Targan, Subrata Ghosh, Willem J. de Villiers, Jean–Frédéric Colombel, Zsolt Tulassay, Ursula Seidler, Bruce Salzberg, Pierre Desreumaux, Scott D. Lee, Edward V. Loftus, Levinus A. Dieleman, Seymour Katz, Paul Rutgeerts - New England Journal of Medicine 2016 被引用: 1,806

  3. Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease

    著者: William J. Sandborn, Brian G. Feagan, Paul Rutgeerts, Stephen B. Hanauer, Jean‐Frédéric Colombel, Bruce E. Sands, Milan Lukáš, Richard N. Fedorak, Scott Lee, Brian Bressler, Irving H. Fox, Maria Rosario, Serap Sankoh, Jing Xu, Kristin Stephens, Catherine Milch, Asit Parikh - New England Journal of Medicine 2013 被引用: 2,687

  4. Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis

    著者: Paul Rutgeerts, William J. Sandborn, Brian G. Feagan, Walter Reinisch, Allan Olson, Jewel Johanns, Suzanne Travers, Daniel Rachmilewitz, Stephen B. Hanauer, Gary R. Lichtenstein, Willem J.S. de Villiers, Daniel H. Present, Bruce E. Sands, Jean‐Frédéric Colombel - New England Journal of Medicine 2005 被引用: 3,883

  5. Ozanimod as Induction and Maintenance Therapy for Ulcerative Colitis

    著者: William J. Sandborn, Brian G. Feagan, Geert D’Haens, Douglas C. Wolf, Igor Jovanović, Stephen B. Hanauer, Subrata Ghosh, AnnKatrin Petersen, Steven Y. Hua, Ji Hwan Lee, Lorna Charles, Denesh K. Chitkara, Keith Usiskin, Jean–Frédéric Colombel, Loren Laine, Silvio Danese - New England Journal of Medicine 2021 被引用: 532

  6. Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target

    著者: Laurent Peyrin‐Biroulet, William J. Sandborn, Bruce E. Sands, Walter Reinisch, Willem A. Bemelman, Robert V. Bryant, Geert D’Haens, Iris Dotan, Marla C. Dubinsky, Brian G. Feagan, Gionata Fiorino, Richard B. Gearry, Suneeta Krishnareddy, Péter L. Lakatos, Edward V. Loftus, Philippe Marteau, Pia Munkholm, Travis B. Murdoch, Íngrid Ordás, Remo Panaccione, Robert H. Riddell, Joannie Ruel, David T. Rubin, Mark Samaan, Corey A. Siegel, Mark S. Silverberg, Jaap Stoker, S Schreiber, Simon Travis, Gert Van Assche, Silvio Danese, Julián Panés, Guillaume Bouguen, Sarah O’Donnell, Benjamin Pariente, Shawn Winer, Stephen B. Hanauer, J -F Colombel - The American Journal of Gastroenterology 2015 被引用: 1,838

  7. Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

    著者: Stephen B. Hanauer, Brian G. Feagan, Gary R. Lichtenstein, Lloyd Mayer, Stefan Schreiber, Jean‐Frédéric Colombel, Daniel Rachmilewitz, Douglas C. Wolf, Allan Olson, Weihang Bao, Paul Rutgeerts - The Lancet 2002 被引用: 4,163

  8. Ustekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with moderately to severely active Crohn's disease: a multicentre, randomised, double-blind, parallel-group, phase 3b trial

    著者: Bruce E. Sands, Peter M. Irving, Timothy Hoops, James Izanec, Long-Long Gao, Christopher Gasink, Andrew Greenspan, Matthieu Allez, Silvio Danese, Stephen B. Hanauer, Vipul Jairath, Tanja Kuehbacher, James D. Lewis, Edward V. Loftus, Emese Mihály, Remo Panaccione, Ellen Scherl, О. Б. Щукина, William J. Sandborn, Anita Afzali, Lilia Aitova, Xavier Aldeguer i Mante, Matthieu Allez, I Altorjay, Federico Argüelles‐Arias, Alessandro Armuzzi, Monika Augustyn, Mauro Bafutto, Jésus Barrio, Jakob Begun, Clint Behrend, Geert Bezemer, Guillaume Bonnaud, Marija Branković, Ik Jang Byung, Xavier Calvet, Karen A. Chachu, Júlio Maria Fonseca Chebli, Jae Hee Cheon, Halina Cichoż‐Lach, Larry Clark, Fraser Cummings, Kunal Dalal, Silvio Danese, Nanne K.H. de Boer, Maria de Lourdes Abreu Ferrari, Étienne Désilets, Predrag Dugalić, George Duvall, Olga Fedorishina, Rafał Filip, Cristina Flores, Ronald Fogel, James Fon, Michael Frankel, Keith Friedenberg, Walter Fries, Vassileva Galina, Piotr Gietka, Rishi Goel, Peter Hasselblatt, Hans Herfarth, László Herszényi, Pieter Hindryckx, Frank Hoentjen, Carmen Horjus Talabur Horje, Satish Iduru, Peter M. Irving, Robert J. Isfort, Vipul Jairath, Michael Jones, Dilara Kalimullina, Jeffry Katz, Manreet Kaur, Sunil K Khurana, Joo Sung Kim, Young‐Ho Kim, D Kleczkowski, Slavko Knezevic, Aaron Knoll, Louis Y Korman, Iskren Kotzev, Andrey Kulyapin, Kang‐Moon Lee, Desirée Leemreis, Jarosław Leszczyszyn, Jimmy K. Limdi, Jack J. Lissauer, Edward V. Loftus, Ewa Małecka‐Panas, John K. Marshall, Emese Mihály, Lukáš Milan, Giovanni Monteleone, Aleksandar Nagorni, Danuta Owczarek, Nichole Palekar, Remo Panaccione, Young Soo Park, Sang Hyoung Park ほか 43 名 - The Lancet 2022 被引用: 297

  9. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease

    著者: Yasunori Ogura, Denise K. Bonen, Naohiro Inohara, Dan L. Nicolae, Felicia F. Chen, Richard Ramos, Heidi Britton, Thomas Moran, Reda Karaliuskas, Richard H. Duerr, Jean–Paul Achkar, Steven R. Brant, Theodore M. Bayless, Barbara S. Kirschner, Stephen B. Hanauer, Gabriel Núñez, Judy H. Cho - Nature 2001 被引用: 5,033

  10. Adalimumab for Maintenance of Clinical Response and Remission in Patients With Crohn’s Disease: The CHARM Trial

    著者: Jean–Frédéric Colombel, William J. Sandborn, Paul Rutgeerts, Robert Enns, Stephen B. Hanauer, Remo Panaccione, Stefan Schreiber, Dan Byczkowski, Ju Li, Jeffrey D. Kent, Paul F. Pollack - Gastroenterology 2006 被引用: 2,250

  11. Ustekinumab Induction and Maintenance Therapy in Refractory Crohn's Disease

    著者: William J. Sandborn, Christopher Gasink, Long-Long Gao, Marion Blank, Jewel Johanns, Cynthia Guzzo, Bruce E. Sands, Stephen B. Hanauer, Stephan R. Targan, Paul Rutgeerts, Subrata Ghosh, Willem J.S. de Villiers, Remo Panaccione, Gordon R. Greenberg, Stefan Schreiber, Simon Lichtiger, Brian G. Feagan - New England Journal of Medicine 2012 被引用: 1,128

  12. Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS)

    著者: Simon Travis, Dan Schnell, Piotr Krzeski, María T. Abreu, Douglas G. Altman, Jean–Frédéric Colombel, Brian G. Feagan, Stephen B. Hanauer, Marc Lémann, Gary R. Lichtenstein, Phillippe R Marteau, Walter Reinisch, Bruce E. Sands, Bruce Yacyshyn, Christian A. Bernhardt, Jean‐Yves Mary, William J. Sandborn - Gut 2011 被引用: 626

  13. Neutrophil-induced genomic instability impedes resolution of inflammation and wound healing

    著者: Veronika Butin‐Israeli, Triet M. Bui, Hannah L. Wiesolek, Lorraine Mascarenhas, Joseph J. Lee, Lindsey Catherine Mehl, Kaitlyn R. Knutson, Stephen A. Adam, Robert D. Goldman, Arthur Beyder, Lisa Wiesmüller, Stephen B. Hanauer, Ronen Sumagin - Journal of Clinical Investigation 2019 被引用: 231

  14. A Short-Term Study of Chimeric Monoclonal Antibody cA2 to Tumor Necrosis Factor α for Crohn's Disease

    著者: Stephan R. Targan, Stephen B. Hanauer, Sander J. H. van Deventer, Lloyd Mayer, Daniel H. Present, Tanja Braakman, Kimberly L. DeWoody, T Schaible, Paul Rutgeerts - New England Journal of Medicine 1997 被引用: 3,160

  15. Infliximab for the Treatment of Fistulas in Patients with Crohn's Disease

    著者: Daniel H. Present, Paul Rutgeerts, Stephan Targan, Stephen B. Hanauer, Lloyd Mayer, R. A. van Hogezand, Daniel K. Podolsky, Bruce E. Sands, Tanja Braakman, Kimberly L. DeWoody, T Schaible, Sander J. H. van Deventer - New England Journal of Medicine 1999 被引用: 2,747

  16. Human Anti–Tumor Necrosis Factor Monoclonal Antibody (Adalimumab) in Crohn’s Disease: the CLASSIC-I Trial

    著者: Stephen B. Hanauer, William J. Sandborn, Paul Rutgeerts, Richard N. Fedorak, Milan Lukáš, Donald MacIntosh, Remo Panaccione, Douglas C. Wolf, Paul Pollack - Gastroenterology 2006 被引用: 1,716

  17. Effects of Vedolizumab Induction Therapy for Patients With Crohn’s Disease in Whom Tumor Necrosis Factor Antagonist Treatment Failed

    著者: Bruce E. Sands, Brian G. Feagan, Paul Rutgeerts, Jean‐Frédéric Colombel, William J. Sandborn, Richmond Sy, Geert D’Haens, Shomron Ben‐Horin, Jing Xu, Maria Rosario, Irving H. Fox, Asit Parikh, Catherine Milch, Stephen B. Hanauer - Gastroenterology 2014 被引用: 705

  18. Early Mucosal Healing With Infliximab Is Associated With Improved Long-term Clinical Outcomes in Ulcerative Colitis

    著者: Jean‐Frédéric Colombel, Paul Rutgeerts, Walter Reinisch, Dirk Eßer, Yanxin Wang, Yinghua Lang, Colleen Marano, Richard Strauß, B.J. Oddens, Brian G. Feagan, Stephen B. Hanauer, Gary R. Lichtenstein, Daniel H. Present, Bruce E. Sands, William J. Sandborn - Gastroenterology 2011 被引用: 919

  19. Reliability and Initial Validation of the Ulcerative Colitis Endoscopic Index of Severity

    著者: Simon Travis, Dan Schnell, Piotr Krzeski, María T. Abreu, Douglas G. Altman, Jean–Frédéric Colombel, Brian G. Feagan, Stephen B. Hanauer, Gary R. Lichtenstein, Philippe Marteau, Walter Reinisch, Bruce E. Sands, Bruce Yacyshyn, Patrick Schnell, Christian A. Bernhardt, Jean–Yves Mary, William J. Sandborn - Gastroenterology 2013 被引用: 446

  20. Defining Disease Severity in Inflammatory Bowel Diseases: Current and Future Directions

    著者: Laurent Peyrin‐Biroulet, Julián Panés, William J. Sandborn, Séverine Vermeire, Silvio Danese, Brian G. Feagan, Jean‐Frédéric Colombel, Stephen B. Hanauer, Beth K. Rycroft - Clinical Gastroenterology and Hepatology 2015 被引用: 446

  21. Ozanimod Induction and Maintenance Treatment for Ulcerative Colitis

    著者: William J. Sandborn, Brian G. Feagan, Douglas C. Wolf, Geert D’Haens, Séverine Vermeire, Stephen B. Hanauer, Subrata Ghosh, Heather Smith, Matthew Cravets, Paul Frohna, Richard Aranda, Sheila Gujrathi, Allan Olson - New England Journal of Medicine 2016 被引用: 445

  22. Five-Year Efficacy and Safety of Ustekinumab Treatment in Crohn’s Disease: The IM-UNITI Trial

    著者: William J. Sandborn, Rory Rebuck, Yuhua Wang, Bin Zou, Omoniyi J. Adedokun, Christopher Gasink, Bruce E. Sands, Stephen B. Hanauer, Stephan R. Targan, Subrata Ghosh, Willem J.S. de Villiers, Jean‐Frédéric Colombel, Brian G. Feagan, John P. Lynch - Clinical Gastroenterology and Hepatology 2021 被引用: 240

  23. Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial

    著者: Walter Reinisch, William J. Sandborn, Daniël W. Hommes, G. D’Haens, Stephen B. Hanauer, Stefanie Schreiber, Remo Panaccione, Richard N. Fedorak, Mary Beth Tighe, Bidan Huang, Wendy Kampman, Andreas Lazar, Roopal Thakkar - Gut 2011 被引用: 887

  24. A Review of Activity Indices and Efficacy End Points for Clinical Trials of Medical Therapy in Adults With Ulcerative Colitis

    著者: Geert D’Haens, William J. Sandborn, Brian G. Feagan, Karel Geboes, Stephen B. Hanauer, E. Jan Irvine, Marc Lémann, Philippe Marteau, Paul Rutgeerts, Jürgen Schölmerich, Lloyd R. Sutherland - Gastroenterology 2006 被引用: 1,208